Detalhe da pesquisa
1.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol
; 24(8): 913-924, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414060
2.
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 200(2): 187-196, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210485
3.
Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period.
Br J Haematol
; 196(3): 649-659, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622447
4.
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
Ann Hematol
; 100(12): 2997-3005, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463804
5.
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
Br J Haematol
; 191(1): 52-61, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32510599
6.
Carcinocythaemia in an advanced stage of invasive ductal carcinoma of the breast.
Br J Haematol
; 185(1): 8, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30474859
7.
Early T-cell precursor lymphoblastic leukaemia: response to FLAG-IDA and high-dose cytarabine with sorafenib after initial refractoriness.
Br J Haematol
; 185(4): 755-757, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334573
8.
The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma.
Hemasphere
; 8(5): e76, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716147
9.
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma.
J Clin Oncol
; 42(14): 1665-1675, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358946
10.
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.
Clin Cancer Res
; 30(10): 2085-2096, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466644
11.
Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review.
Front Oncol
; 13: 1217714, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37637047
12.
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution.
Cancers (Basel)
; 15(21)2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958434
13.
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution.
Blood Cancer J
; 12(9): 135, 2022 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114167
14.
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells.
Mol Ther Methods Clin Dev
; 26: 207-223, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859694
15.
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma.
Front Oncol
; 12: 936993, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35865461
16.
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Blood Adv
; 6(4): 1193-1206, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911079
17.
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome.
Sci Adv
; 8(39): eabo0514, 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179026
18.
Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.
Cancers (Basel)
; 13(9)2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922804
19.
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma.
J Immunother Cancer
; 9(12)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876408
20.
Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma.
Clin Cancer Res
; 26(17): 4688-4698, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513837